EGFR-TKIs sometimes cause drastic tumor regression in specific subgroups of patients with advanced NSCLC, including women, non-smokers, patients with lung adenocarcinoma (ADC) histology, patients of Asian origin and patients with EGFR mutations [2-6]. The gene discussed is EGFR; the disease is lung adenocarcinoma.